The Oncology Institute, Inc. (TOI) Misses Q1 EPS by 16c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q1 EPS of ($0.33), $0.16 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $76 million versus the consensus estimate of $67 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Arrive AI and DXC Technology partner to bring delivery tech to factories
• Anthropic delays planned IPO from October to November - WSJ